These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36565366)

  • 1. A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening.
    Kowada A
    Dig Dis Sci; 2023 May; 68(5):1735-1746. PubMed ID: 36565366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Population-Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation.
    Kowada A
    Helicobacter; 2024; 29(4):e13120. PubMed ID: 39138610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
    Kowada A
    Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
    Kowada A; Asaka M
    Helicobacter; 2021 Oct; 26(5):e12837. PubMed ID: 34278663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of
    Kowada A
    Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan.
    Kowada A
    Epidemiol Infect; 2018 Oct; 146(14):1834-1840. PubMed ID: 30056808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation.
    Wang Z; Han W; Xue F; Zhao Y; Wu P; Chen Y; Yang C; Gu W; Jiang J
    Gut; 2022 Dec; 71(12):2391-2400. PubMed ID: 35902213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
    Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
    Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention.
    Ma J; Yu M; Shao QQ; Yu XC; Zhang C; Zhao JB; Yuan L; Qi YB; Hu RB; Wei PR; Xiao W; Chen Q; Jia BL; Chen CL; Lu H; Ding SZ
    Helicobacter; 2022 Aug; 27(4):e12911. PubMed ID: 35706404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.
    Han Y; Yan T; Ma H; Yao X; Lu C; Li Y; Li L
    Dig Dis Sci; 2020 Jun; 65(6):1679-1688. PubMed ID: 31673902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost effectiveness of Helicobacter pylori population screening-economic evaluation alongside a randomised controlled trial with 13-year follow-up.
    Høgh MB; Kronborg C; Hansen JM; Schaffalitzky de Muckadell OB
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1013-1025. PubMed ID: 30854700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis.
    Kowada A; Asaka M
    Helicobacter; 2022 Jun; 27(3):e12886. PubMed ID: 35343031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of the Helicobacter Pylori Screening Programme in an Asymptomatic Population in China.
    Feng T; Zheng Z; Xu J; Cao P; Gao S; Yu X
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.
    Xie F; Luo N; Lee HP
    World J Gastroenterol; 2008 May; 14(19):3021-7. PubMed ID: 18494053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of different screening strategies for helicobacter pylori infection in Iran: A model-based evaluation.
    Yousefi M; Rezaei S; Khoshbaten M; Sarmasti M
    Helicobacter; 2023 Dec; 28(6):e13027. PubMed ID: 37839058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
    Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and eradication of
    Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
    Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity.
    Teng AM; Kvizhinadze G; Nair N; McLeod M; Wilson N; Blakely T
    BMC Infect Dis; 2017 Feb; 17(1):156. PubMed ID: 28219322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic screening for gastric cancer.
    Dan YY; So JB; Yeoh KG
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.